Acupuncture at PC6 prevents cardiac hypertrophy in isoproterenol-treated mice

Abstract

Objectives:

To investigate the effect of acupuncture at PC6 on cardiac hypertrophy in isoproterenol (ISO)-treated mice.

Methods:

48 male C57BL/6 mice underwent subcutaneous injection of ISO for 14 days and were randomly divided into four groups (n=12 each) that remained untreated (ISO group), received verum manual acupuncture (MA) treatment at PC6 (ISO+MA(PC6) group), sham MA at location on the tail not corresponding to any traditional acupuncture point (ISO+MA(tail) group), or propranolol (ISO+PR group). An additional 12 mice were given an injection of phosphate-buffered saline (PBS) and formed a healthy control (Normal) group. After performing echocardiography and measuring the ratio of heart weight (HW)/tibia length (TL) at 14 days, all mice were euthanased. Morphological examination was performed following haematoxylin and eosin and Masson’s staining of heart tissues. Ultrastructural changes were observed by electron microscopy. Cardiac protein expression of atrial natriuretic peptide (ANP) and tumour necrosis factor α (TNFα) were measured by immunohistochemical (IHC) staining and Western blotting.

Results:

Compared with the untreated model group, acupuncture at PC6 lowered the heart rate, reduced the ratio of HW/TL, improved the left ventricular (LV) anterior wall thickness (LVAWd), LV end-diastolic anterior wall thickness (LVAWs), LV end-systolic posterior wall thickness (LVPWd), LV end-diastolic posterior wall thickness (LVPWs), and fractional shortening (FS) as observed by echocardiography (ISO+MA(PC6) vs. ISO groups: P<0.05). Moreover, evidence from morphological studies demonstrated that acupuncture at PC6 inhibited myocardial hypertrophy and collagen deposition, and normalised the ultrastructural changes. In addition, ANP and TNFα expression were attenuated in the verum acupuncture group compared with the untreated model group (ISO+MA(PC6) vs. ISO groups: P<0.05).

Conclusions:

The results demonstrated that acupuncture at PC6 attenuates sympathetic overactivity. Additionally, it may improve cardiac performance by reversing adverse cardiac remodelling. Acupuncture has potential as a treatment for sympathetic hypertension.

Keywords

acupuncture cardiac remodelling cardiac hypertrophy isoproterenol atrial natriuretic peptide

Get full access to this article

View all access options for this article.

References

Sandler

Dodge

. Left ventricular tension and stress in man. Circ Res 1963; 13: 91–104.

Grossman

Jones

McLaurin

. Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest 1975; 56: 56–64.

Koren

Devereux

Casale

, et al. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 114: 345–52.

Lohse

Engelhardt

Eschenhagen

. What is the role of beta-adrenergic signaling in heart failure? Circ Res 2003; 93: 896–906.

Run-Ming

. The origin and development of Chinese acupuncture and moxibustion. Anc Sci Life 1985; 4: 224–8.

Longhurst

. Acupuncture’s cardiovascular actions: a mechanistic perspective. Med Acupunct 2013; 25: 101–13.

White

. The web that has no weaver: understanding Chinese medicine. Focus on Alternative and Complementary Therapies 2001; 6: 45.

Wang

Kuo

Yang

. An alternative method to enhance vagal activities and suppress sympathetic activities in humans. Auton Neurosci 2002; 100: 90–5.

Torres-Rosas

Yehia

Peña

, et al. Dopamine mediates vagal modulation of the immune system by electroacupuncture. Nat Med 2014; 20: 291–5.

10.

Eshkevari

Egan

Phillips

, et al. Acupuncture at ST36 prevents chronic stress-induced increases in neuropeptide Y in rat. Exp Biol Med 2012; 237: 18–23.

11.

Liang

, et al. Electroacupuncture at PC6 (Neiguan) improves extracellular signal-regulated kinase signaling pathways through the regulation of neuroendocrine cytokines in myocardial hypertrophic rats. Evid Based Complement Alternat Med 2012; 2012: 1–9.

12.

Chang Lee

Shibu

, et al. Protective effects of electroacupuncture at LR3 on cardiac hypertrophy and apoptosis in hypertensive rats. Acupunct Med 2016; 34: 201–8.

13.

Ryu

Jin

Kee

, et al. Gallic acid prevents isoproterenol-induced cardiac hypertrophy and fibrosis through regulation of JNK2 signaling and Smad3 binding activity. Sci Rep 2016; 6: 34790.

14.

Zhu

, et al. Acupuncture prevents the atrial fibrillation through improving remodeling of atrial appendage in rats. J Tradi Med Clin Natur 2016; 5: 2.

15.

Slot

Geuze

. Cryosectioning and immunolabeling. Nat Protoc 2007; 2: 2480–91.

16.

Golomb

Abassi

Cuda

, et al. Angiotensin II maintains, but does not mediate, isoproterenol-induced cardiac hypertrophy in rats. Am J Physiol 1994; 267: H1496–H1506.

17.

Vidal

Wieland

Lohse

, et al. β-Adrenergic receptor stimulation causes cardiac hypertrophy via a Gβγ/Erk-dependent pathway. Cardiovasc Res 2012; 96: 255–64.

18.

Flachskampf

Gallasch

Gefeller

, et al. Randomized trial of acupuncture to lower blood pressure. Circulation 2007; 115: 3121–9.

19.

Jonkman

Jonkman-Buidin

. Integrated approach to treatment-resistant atrial fibrillation: additional value of acupuncture. Acupunct Med 2013; 31: 327–30.

20.

Liu

Park

Shin

, et al. Acupuncture lowers blood pressure in mild hypertension patients: a randomized, controlled, assessor-blinded pilot trial. Complement Ther Med 2015; 23: 658–65.

21.

Mori

Chen

Feng

, et al. Volume overload results in exaggerated cardiac hypertrophy in the atrial natriuretic peptide knockout mouse. Cardiovasc Res 2004; 61: 771–9.

22.

Ichiki

Burnett

. Atrial natriuretic peptide– old but new therapeutic in cardiovascular diseases. Circ J 2017; 81: 913–9.

23.

Nef

Möllmann

Akashi

, et al. Mechanisms of stress (Takotsubo) cardiomyopathy. Nat Rev Cardiol 2010; 7: 187–93.

24.

Huang

Webb

Zourdos

, et al. Cardiovascular reactivity, stress, and physical activity. Front Physiol 2013; 4: 314.

25.

Murray

Prabhu

Chandrasekar

. Chronic beta-adrenergic stimulation induces myocardial proinflammatory cytokine expression. Circulation 2000; 101: 2338–41.

26.

Garlie

Hamid

, et al. Tumor necrosis factor receptor 2 signaling limits β-adrenergic receptor-mediated cardiac hypertrophy in vivo. Basic Res Cardiol 2011; 106: 1193–205.

27.

Yokoyama

Nakano

Bednarczyk

, et al. Tumor necrosis factor-alpha provokes a hypertrophic growth response in adult cardiac myocytes. Circulation 1997; 95: 1247–52.